Home Page

LYFE for LIFE

Amplifying healthcare through value creation

LYFE for LIFE

Amplifying healthcare through value creation

Who we are

LYFE is a global healthcare investment firm and platform dedicated to amplification of healthcare through value creation.

We work with multi-stage companies with promising fast growth potentials and provide capital and acceleration, allowing them to realize their maximum potential in a dynamic environment. With our team of extremely globally knowledgeable healthcare and investment professionals, we are able to work with flexibility pivoting our investment strategy to match each and every portfolio need. This had led us to invest across global markets, primarily those in Greater China and the North America with the goal of bridge the gap through value generation.

20+
Professionals
$1.1B
Assets Under Management
14+
Medical Specialties Covered

Media Center

FREMONT, Calif., July 22, 2021 (GLOBE NEWSWIRE) — Cytek Biosciences, Inc. (“Cytek Biosciences” or “Cytek”) (Nasdaq: CTKB), a leading cell analysis solutions company, announced today the pricing of its initial public offering of an aggregate of 16,749,330 shares of its common stock at a price to the public of $17.00 per share. The gross proceeds […]

Read More